Leave a Nest Capital Invests in Wizray Co., Ltd.

Leave a Nest Group, through Leave a Nest Capital Co., Ltd. has invested in Wizray Co., Ltd. (Head Office: Okayama City, Japan; CEO: Dr. Kei Moriyama; hereinafter “Wizray”), a spin-off from from Shujitsu University and a finalist at the Okayama Tech Planter 2018.

Wizray Co., Ltd. holds the vision to “Build a society with zero medical accidents caused by drug administration” and is engaged in providing systems for identifying prescription drugs using spectroscopic analysis technology.

Leave a Nest Group has decided to invest in TearExo due to their shared commitment to build a society where pharmacists can shift to working more closely with patients, contributing to their health promotion and reducing health damage caused by counterfeit drugs around the world.

With this funding, Wizray aims to expand its business, focusing on expanding manufacturing and sales partnerships and pursuing overseas expansion.

Moving forward, Leave a Nest Group will continue to create deep technology that solves deep issues in healthcare and contribute to global happiness.

About Wizray

• Company Name: Wizray Co., Ltd.
• Website: https://wizray.jp/
• Head Office: 4F Daiichi Central Building, 6-36 Honmachi, Kita-ku, Okayama City, Okayama Prefecture, Japan
• CEO: Dr. Kei Moriyama
• Incorporation: 11 July 2019